36 related articles for article (PubMed ID: 7713141)
1. Rolipram, a cyclic AMP-selective phosphodiesterase inhibitor, reduces neuronal damage following cerebral ischemia in the gerbil.
Kato H; Araki T; Itoyama Y; Kogure K
Eur J Pharmacol; 1995 Jan; 272(1):107-10. PubMed ID: 7713141
[TBL] [Abstract][Full Text] [Related]
2. Effect of carvedilol on neuronal survival and poly(ADP-ribose) polymerase activity in hippocampus after transient forebrain ischemia.
Strosznajder RP; Jesko H; Dziewulska J
Acta Neurobiol Exp (Wars); 2005; 65(2):137-43. PubMed ID: 15960297
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional Factors and Protein Biomarkers as Target Therapeutics in Traumatic Spinal Cord and Brain Injury.
Kumar S; Fritz Z; Sulakhiya K; Theis T; Berthiaume F
Curr Neuropharmacol; 2020; 18(11):1092-1105. PubMed ID: 32442086
[TBL] [Abstract][Full Text] [Related]
4. Targeting phosphodiesterase 4 as a potential therapeutic strategy for enhancing neuroplasticity following ischemic stroke.
Wang H; Gaur U; Xiao J; Xu B; Xu J; Zheng W
Int J Biol Sci; 2018; 14(12):1745-1754. PubMed ID: 30416389
[TBL] [Abstract][Full Text] [Related]
5. Transcription factors Tp73, Cebpd, Pax6, and Spi1 rather than DNA methylation regulate chronic transcriptomics changes after experimental traumatic brain injury.
Lipponen A; El-Osta A; Kaspi A; Ziemann M; Khurana I; Kn H; Navarro-Ferrandis V; Puhakka N; Paananen J; Pitkänen A
Acta Neuropathol Commun; 2018 Feb; 6(1):17. PubMed ID: 29482641
[TBL] [Abstract][Full Text] [Related]
6. Gene Profiling of Nucleus Basalis Tau Containing Neurons in Chronic Traumatic Encephalopathy: A Chronic Effects of Neurotrauma Consortium Study.
Mufson EJ; He B; Ginsberg SD; Carper BA; Bieler GS; Crawford F; Alvarez VE; Huber BR; Stein TD; McKee AC; Perez SE
J Neurotrauma; 2018 Jun; 35(11):1260-1271. PubMed ID: 29338612
[TBL] [Abstract][Full Text] [Related]
7. Traumatic Brain Injury Upregulates Phosphodiesterase Expression in the Hippocampus.
Wilson NM; Titus DJ; Oliva AA; Furones C; Atkins CM
Front Syst Neurosci; 2016; 10():5. PubMed ID: 26903822
[TBL] [Abstract][Full Text] [Related]
8. Phosphodiesterase 4D gene polymorphisms in sudden sensorineural hearing loss.
Chien CY; Tai SY; Wang LF; Hsi E; Chang NC; Wang HM; Wu MT; Ho KY
Eur Arch Otorhinolaryngol; 2016 Sep; 273(9):2403-9. PubMed ID: 26521189
[TBL] [Abstract][Full Text] [Related]
9. Effects of PDE4 pathway inhibition in rat experimental stroke.
Yang F; Sumbria RK; Xue D; Yu C; He D; Liu S; Paganini-Hill A; Fisher M
J Pharm Pharm Sci; 2014; 17(3):362-70. PubMed ID: 25224348
[TBL] [Abstract][Full Text] [Related]
10. Phosphodiesterase inhibitors as therapeutics for traumatic brain injury.
Titus DJ; Oliva AA; Wilson NM; Atkins CM
Curr Pharm Des; 2015; 21(3):332-42. PubMed ID: 25159077
[TBL] [Abstract][Full Text] [Related]
11. Effects of early rolipram treatment on histopathological outcome after controlled cortical impact injury in mice.
Atkins CM; Cepero ML; Kang Y; Liebl DJ; Dietrich WD
Neurosci Lett; 2013 Jan; 532():1-6. PubMed ID: 23103712
[TBL] [Abstract][Full Text] [Related]
12. Postinjury treatment with rolipram increases hemorrhage after traumatic brain injury.
Atkins CM; Kang Y; Furones C; Truettner JS; Alonso OF; Dietrich WD
J Neurosci Res; 2012 Sep; 90(9):1861-71. PubMed ID: 22535545
[TBL] [Abstract][Full Text] [Related]
13. Prevention of cerebral ischemia-induced memory deficits by inhibition of phosphodiesterase-4 in rats.
Li LX; Cheng YF; Lin HB; Wang C; Xu JP; Zhang HT
Metab Brain Dis; 2011 Mar; 26(1):37-47. PubMed ID: 21327879
[TBL] [Abstract][Full Text] [Related]
14. A large-scale chemical screen for regulators of the arginase 1 promoter identifies the soy isoflavone daidzeinas a clinically approved small molecule that can promote neuronal protection or regeneration via a cAMP-independent pathway.
Ma TC; Campana A; Lange PS; Lee HH; Banerjee K; Bryson JB; Mahishi L; Alam S; Giger RJ; Barnes S; Morris SM; Willis DE; Twiss JL; Filbin MT; Ratan RR
J Neurosci; 2010 Jan; 30(2):739-48. PubMed ID: 20071539
[TBL] [Abstract][Full Text] [Related]
15. Systemic administration of rolipram increases medullary and spinal cAMP and activates a latent respiratory motor pathway after high cervical spinal cord injury.
Kajana S; Goshgarian HG
J Spinal Cord Med; 2009; 32(2):175-82. PubMed ID: 19569465
[TBL] [Abstract][Full Text] [Related]
16. Modulation of the cAMP signaling pathway after traumatic brain injury.
Atkins CM; Oliva AA; Alonso OF; Pearse DD; Bramlett HM; Dietrich WD
Exp Neurol; 2007 Nov; 208(1):145-58. PubMed ID: 17916353
[TBL] [Abstract][Full Text] [Related]
17. Multiple actions of the human immunodeficiency virus type-1 Tat protein on microglial cell functions.
Minghetti L; Visentin S; Patrizio M; Franchini L; Ajmone-Cat MA; Levi G
Neurochem Res; 2004 May; 29(5):965-78. PubMed ID: 15139295
[TBL] [Abstract][Full Text] [Related]
18. Effects of a phosphodiesterase IV inhibitor rolipram on microsphere embolism-induced defects in memory function and cerebral cyclic AMP signal transduction system in rats.
Nagakura A; Niimura M; Takeo S
Br J Pharmacol; 2002 Apr; 135(7):1783-93. PubMed ID: 11934820
[TBL] [Abstract][Full Text] [Related]
19. Effects of inhibition of PDE4 and TNF-alpha on local and remote injuries following ischaemia and reperfusion injury.
Souza DG; Cassali GD; Poole S; Teixeira MM
Br J Pharmacol; 2001 Nov; 134(5):985-94. PubMed ID: 11682446
[TBL] [Abstract][Full Text] [Related]
20. Involvement of cyclic AMP systems in morphine physical dependence in mice: prevention of development of morphine dependence by rolipram, a phosphodiesterase 4 inhibitor.
Mamiya T; Noda Y; Ren X; Hamdy M; Furukawa S; Kameyama T; Yamada K; Nabeshima T
Br J Pharmacol; 2001 Mar; 132(5):1111-7. PubMed ID: 11226142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
